Arazasetron

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameArazasetron
Drug Alias NameR-azasetron besylateSENS-401(R)-Azasetron besylate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor agonistsCalcineurin inhibitors
TargetsSerotonin 3 (5-HT3) receptorCalcineurin
Therapy Area/IndicationsLabyrinth DiseasesHearing Loss, SensorineuralHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[11] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSensorion Sa
China Registration ClassN/A

Develop Information

Active CompaniesSensorion Sa
Inactive CompaniesSimbec Research Ltd
Active IndicationsHearing Loss, SensorineuralHearing Loss
Inactive IndicationsLabyrinth Diseases

Other Information

ATC CodeN/A
Related LinksN/A